Verrica Pharmaceuticals Inc. (VRCA)
$3.83+6.98%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $41M
- Beta
- 1.61
- P/E (TTM)
- -2.20
- Short % float
- 2.90%
- Days to cover
- 4.1
- SI change
- -3.2%
- 1W
- -7.49%
- 1M
- -16.38%
- vs SPY 1W
- -6.51%
- vs SPY 1M
- -18.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VRCA?
- LOPJLB’s latest quantitative signal on Verrica Pharmaceuticals Inc. (VRCA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VRCA in?
- Verrica Pharmaceuticals Inc. (VRCA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Verrica Pharmaceuticals Inc. (VRCA) do?
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the …